Published in
Elsevier, Clinical Breast Cancer, 6(21), p. 539-551, 2021
DOI: 10.1016/j.clbc.2021.04.011
Links
Tools
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study
Journal article published in 2021 by
Erika P. Hamilton,
Virginia Kaklamani,
Carla Falkson,
Gregory A. Vidal,
Patrick J. Ward 
,
Monika Patre,
Stephen Y. Chui,
Jacob Rotmensch,
Kushagra Gupta,
Luciana Molinero,
Yijin Li,
Leisha A. Emens
,
Monika Patre,
Stephen Y. Chui,
Jacob Rotmensch,
Kushagra Gupta,
Luciana Molinero,
Yijin Li,
Leisha A. Emens
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 